Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study
暂无分享,去创建一个
[1] L. Esserman,et al. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial , 2017, JAMA oncology.
[2] N. Panay,et al. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. , 2017, Fertility and sterility.
[3] J. Pinkerton. The 2017 hormone therapy position statement of The North American Menopause Society. , 2017, Menopause.
[4] A. Pinto-Neto,et al. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial , 2016, Menopause.
[5] F. Labrie,et al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause , 2016, Menopause.
[6] S. Davis,et al. Testosterone in women--the clinical significance. , 2015, The lancet. Diabetes & endocrinology.
[7] A. Pinto-Neto,et al. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial. , 2014, The journal of sexual medicine.
[8] M. Martens,et al. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society , 2013, Menopause.
[9] A. Perrone,et al. Androgen receptor expression in the human vagina under different physiological and treatment conditions , 2013, International Journal of Impotence Research.
[10] B. Littenberg,et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. , 2011, The oncologist.
[11] L. Derogatis,et al. Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study. , 2011, Fertility and sterility.
[12] C. Stika. Atrophic vaginitis , 2010, Dermatologic therapy.
[13] P. Dubey,et al. A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. , 2010, The journal of sexual medicine.
[14] C. Labrie,et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy , 2009, Menopause.
[15] C. Labrie,et al. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women , 2009, Menopause.
[16] G. Braunstein,et al. Testosterone for low libido in postmenopausal women not taking estrogen. , 2008, The New England journal of medicine.
[17] I. Goldstein,et al. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: immunohistochemical studies. , 2006, The journal of sexual medicine.
[18] C. Castelo-Branco,et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. , 2005, Maturitas.
[19] F. Labrie,et al. Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[20] C. Castelo-Branco,et al. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. , 2005, Maturitas.
[21] A. Lethaby,et al. Local oestrogen for vaginal atrophy in postmenopausal women. , 2003, The Cochrane database of systematic reviews.
[22] T. Bourne,et al. Ultrasound in gynecology: endometrium , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[23] A. Haspels,et al. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects. , 1980, Maturitas.